[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  $alpmy $ALPMY sees increased creator engagement with positive sentiment, despite low overall mentions. Astellas partners with the Korea Institute of Startup and Entrepreneurship Development. ### About $alpmy This is a summary of social media activity related to the topic $ALPMY. ### Insights [#](/topic/$alpmy/insights) - $alpmy creators is up XXXXX% from the previous week. - $alpmy mentions is up XXXXX% from the previous week. - $alpmy Creators hit a high of XX for the day - $alpmy Creators hit an all time of XX for the day ### Engagements: XXX [#](/topic/$alpmy/interactions) ---  [Engagements 24-Hour Chart Data](/topic/$alpmy/time-series/interactions.tsv) **Current Value**: XXX **Daily Average**: XXX **1 Week**: XXX -XX% **1 Month**: XXXXX -XX% **1-Year High**: XXXXX on 2025-05-19 **1-Year Low**: X on 2025-07-04 | Social Network | X | | -------------- | - | | Engagements | XXX | ### Mentions: X [#](/topic/$alpmy/posts_active) ---  [Mentions 24-Hour Chart Data](/topic/$alpmy/time-series/posts_active.tsv) **Current Value**: X **Daily Average**: X **1 Week**: XX +87% **1 Month**: XX +13% **1-Year High**: XX on 2025-05-30 **1-Year Low**: X on 2025-04-27 | Social Network | X | | -------------- | - | | Mentions | XX | ### Creators: X [#](/topic/$alpmy/contributors_active) ---  [Creators 24-Hour Chart Data](/topic/$alpmy/time-series/contributors_active.tsv) X unique social accounts have posts mentioning $alpmy in the last XX hours which is down XX% from XX in the previous XX hours **Daily Average**: X **1 Week**: XX +89% **1 Month**: XX +64% **1-Year High**: XX on 2025-07-19 **1-Year Low**: X on 2025-04-27 ### Sentiment: XX% [#](/topic/$alpmy/sentiment) ---  [Sentiment 24-Hour Chart Data](/topic/$alpmy/time-series/sentiment.tsv) **Current Value**: XX% **Daily Average**: XX% **1 Week**: XX% -XX% **1 Month**: XX% -XX% **1-Year High**: XXX% on 2025-05-11 **1-Year Low**: XX% on 2025-07-24 **Most Supportive Themes** - **Creator Engagement:** (40%) Creator activity is up, with XX unique accounts posting about $ALPMY, showing increased interest from a dedicated group. - **Positive Sentiment:** (50%) Sentiment is positive at 80%, with the majority of social engagement being neutral, but a significant portion is positive. **Most Critical Themes** - **Low Mentions:** (10%) Mentions of $ALPMY are low, indicating a lack of widespread discussion. Network engagement breakdown: | Network | Positive | % | Neutral | % | Negative | % | | ------- | -------- | - | ------- | - | -------- | - | | X | X | X% | XXX | XXX% | X | X% | | | | | | | | | | Total | X | X% | XXX | XXX% | X | X% | **Top assets mentioned** In the posts about $alpmy in the last XX hours [Pfizer, Inc. (PFE)](/topic/$pfe) [Gilead Sciences, Inc. (GILD)](/topic/$gild) [Gilead Sciences, Inc. (GILD)](/topic/gilead-sciences) [AstraZeneca PLC (AZN)](/topic/$azn) [Apellis Pharmaceuticals, Inc. Common Stock (APLS)](/topic/$apls) [Kymera Therapeutics, Inc. Common Stock (KYMR)](/topic/$kymr) [Bristol-Myers Squibb Co (BMY)](/topic/$bmy) [Regeneron Pharmaceuticals Inc (REGN)](/topic/$regn) [Regeneron Pharmaceuticals Inc (REGN)](/topic/regeneron-pharmaceuticals-inc) [Synthetify (SNY)](/topic/$sny) **Top topics mentioned** In the posts about $alpmy in the last XX hours [stocks healthcare](/topic/stocks-healthcare), [$pfe](/topic/$pfe), [$4503t](/topic/$4503t), [pfe](/topic/pfe), [$rhhby](/topic/$rhhby), [$gild](/topic/$gild), [gilead sciences](/topic/gilead-sciences), [manat](/topic/manat), [$azn](/topic/$azn), [$apls](/topic/$apls), [$kymr](/topic/$kymr), [$dsnky](/topic/$dsnky), [$bmy](/topic/$bmy), [tak](/topic/tak), [$tak](/topic/$tak), [$srzn](/topic/$srzn), [$regn](/topic/$regn), [$eypt](/topic/$eypt), [$ocul](/topic/$ocul), [regeneron pharmaceuticals inc](/topic/regeneron-pharmaceuticals-inc), [$25b](/topic/$25b), [$77m](/topic/$77m), [$sny](/topic/$sny), [$730m](/topic/$730m), [$nrix](/topic/$nrix), [1b](/topic/1b), [$2b](/topic/$2b), [sanofi](/topic/sanofi), [$jnj](/topic/$jnj), [$zlab](/topic/$zlab), [$nvs](/topic/$nvs), [$mgnx](/topic/$mgnx), [$arvn](/topic/$arvn), [johnson johnson](/topic/johnson-johnson), [stocks financial services](/topic/stocks-financial-services), [$bntx](/topic/$bntx), [$lly](/topic/$lly), [$akesf](/topic/$akesf), [$abbv](/topic/$abbv), [$smmt](/topic/$smmt), [$mrk](/topic/$mrk), [eli lilly](/topic/eli-lilly), [investment](/topic/investment), [$bayn](/topic/$bayn), [$gsk](/topic/$gsk), [gsk plc](/topic/gsk-plc), [$jazz](/topic/$jazz), [$cslax](/topic/$cslax), [$sgmo](/topic/$sgmo), [$fold](/topic/$fold), [$1530hk](/topic/$1530hk), [$lyel](/topic/$lyel), [$rvmd](/topic/$rvmd), [$20focus](/topic/$20focus), [$tngx](/topic/$tngx), [$oric](/topic/$oric), [$amgn](/topic/$amgn), [jpmorgan chase](/topic/jpmorgan-chase), [stocks banks](/topic/stocks-banks), [abbv](/topic/abbv), [$mkkgy](/topic/$mkkgy), [$nxtc](/topic/$nxtc), [nrix](/topic/nrix), [$srpt](/topic/$srpt), [$avxs](/topic/$avxs), [$qure](/topic/$qure), [$sldb](/topic/$sldb), [$bold](/topic/$bold), [aav](/topic/aav), [$bmrn](/topic/$bmrn), [sarepta therapeutics inc](/topic/sarepta-therapeutics-inc), [$nilsy](/topic/$nilsy), [$aacay](/topic/$aacay), [$brdcy](/topic/$brdcy), [$pdypy](/topic/$pdypy), [$therf](/topic/$therf), [$mrwsy](/topic/$mrwsy), [$rnlsy](/topic/$rnlsy), [$sipry](/topic/$sipry), [$fujhy](/topic/$fujhy), [$xsnx](/topic/$xsnx), [$phot](/topic/$phot), [$crrfy](/topic/$crrfy), [$fnmah](/topic/$fnmah), [$anzby](/topic/$anzby), [$enlay](/topic/$enlay), [$akzoy](/topic/$akzoy), [$dnkey](/topic/$dnkey), [$hocpy](/topic/$hocpy), [$toely](/topic/$toely), [$hkxcy](/topic/$hkxcy), [$poahy](/topic/$poahy), [$dsdvy](/topic/$dsdvy), [$shcay](/topic/$shcay), [$heiny](/topic/$heiny), [$uovey](/topic/$uovey), [$zurvy](/topic/$zurvy), [$szkmy](/topic/$szkmy), [$lvvv](/topic/$lvvv), [$amkby](/topic/$amkby) ### Top Social Posts [#](/topic/$alpmy/posts) --- Top posts by engagements in the last XX hours *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "Who will be $SGMO business partner for ST-920 #Fabry $TAK $CSL.AX $PFE $FOLD $AZN $ALPMY $FOLD" [@jewcypickle](/creator/x/jewcypickle) on [X](/post/tweet/1946611064264868200) 2025-07-19 16:40:18 UTC XX followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
$ALPMY sees increased creator engagement with positive sentiment, despite low overall mentions. Astellas partners with the Korea Institute of Startup and Entrepreneurship Development.
This is a summary of social media activity related to the topic $ALPMY.
Engagements 24-Hour Chart Data
Current Value: XXX
Daily Average: XXX
1 Week: XXX -XX%
1 Month: XXXXX -XX%
1-Year High: XXXXX on 2025-05-19
1-Year Low: X on 2025-07-04
Social Network | X |
---|---|
Engagements | XXX |
Mentions 24-Hour Chart Data
Current Value: X
Daily Average: X
1 Week: XX +87%
1 Month: XX +13%
1-Year High: XX on 2025-05-30
1-Year Low: X on 2025-04-27
Social Network | X |
---|---|
Mentions | XX |
Creators 24-Hour Chart Data
X unique social accounts have posts mentioning $alpmy in the last XX hours which is down XX% from XX in the previous XX hours
Daily Average: X
1 Week: XX +89%
1 Month: XX +64%
1-Year High: XX on 2025-07-19
1-Year Low: X on 2025-04-27
Sentiment 24-Hour Chart Data
Current Value: XX%
Daily Average: XX%
1 Week: XX% -XX%
1 Month: XX% -XX%
1-Year High: XXX% on 2025-05-11
1-Year Low: XX% on 2025-07-24
Most Supportive Themes
Most Critical Themes
Network engagement breakdown:
Network | Positive | % | Neutral | % | Negative | % |
---|---|---|---|---|---|---|
X | X | X% | XXX | XXX% | X | X% |
Total | X | X% | XXX | XXX% | X | X% |
Top assets mentioned In the posts about $alpmy in the last XX hours
Pfizer, Inc. (PFE) Gilead Sciences, Inc. (GILD) Gilead Sciences, Inc. (GILD) AstraZeneca PLC (AZN) Apellis Pharmaceuticals, Inc. Common Stock (APLS) Kymera Therapeutics, Inc. Common Stock (KYMR) Bristol-Myers Squibb Co (BMY) Regeneron Pharmaceuticals Inc (REGN) Regeneron Pharmaceuticals Inc (REGN) Synthetify (SNY)
Top topics mentioned In the posts about $alpmy in the last XX hours
stocks healthcare, $pfe, $4503t, pfe, $rhhby, $gild, gilead sciences, manat, $azn, $apls, $kymr, $dsnky, $bmy, tak, $tak, $srzn, $regn, $eypt, $ocul, regeneron pharmaceuticals inc, $25b, $77m, $sny, $730m, $nrix, 1b, $2b, sanofi, $jnj, $zlab, $nvs, $mgnx, $arvn, johnson johnson, stocks financial services, $bntx, $lly, $akesf, $abbv, $smmt, $mrk, eli lilly, investment, $bayn, $gsk, gsk plc, $jazz, $cslax, $sgmo, $fold, $1530hk, $lyel, $rvmd, $20focus, $tngx, $oric, $amgn, jpmorgan chase, stocks banks, abbv, $mkkgy, $nxtc, nrix, $srpt, $avxs, $qure, $sldb, $bold, aav, $bmrn, sarepta therapeutics inc, $nilsy, $aacay, $brdcy, $pdypy, $therf, $mrwsy, $rnlsy, $sipry, $fujhy, $xsnx, $phot, $crrfy, $fnmah, $anzby, $enlay, $akzoy, $dnkey, $hocpy, $toely, $hkxcy, $poahy, $dsdvy, $shcay, $heiny, $uovey, $zurvy, $szkmy, $lvvv, $amkby
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"Who will be $SGMO business partner for ST-920 #Fabry $TAK $CSL.AX $PFE $FOLD $AZN $ALPMY $FOLD"
@jewcypickle on X 2025-07-19 16:40:18 UTC XX followers, XXX engagements
/topic/$alpmy